CG
CLOV icon

Cutler Group’s Clover Health Investments CLOV Stock Holding History

Cutler Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$14K Sell
18,000
-294
-2% -$268 ﹤0.01% 1139
2023
Q4 		$17K Sell
18,294
-2,041
-10% -$2K ﹤0.01% 2057
2023
Q3 		$21K Sell
20,335
-782
-4% -$930 ﹤0.01% 1980
2023
Q2 		$18K Sell
21,117
-6,535
-24% -$5.8K ﹤0.01% 1898
2023
Q1 		$23K Sell
27,652
-5,044
-15% -$5.52K ﹤0.01% 1832
2022
Q4 		$30K Sell
32,696
-351
-1% -$468 ﹤0.01% 1931
2022
Q3 		$56K Buy
33,047
+3,739
+13% +$9.79K ﹤0.01% 1803
2022
Q2 		$62K Sell
29,308
-65,427
-69% -$174K ﹤0.01% 1787
2022
Q1 		$336K Buy
94,735
+26,046
+38% +$75.5K 0.02% 870
2021
Q4 		$255K Sell
68,689
-62,517
-48% -$383K 0.01% 1140
2021
Q3 		$969K Buy
131,206
+66,614
+103% +$570K 0.04% 484
2021
Q2 		$860K Buy
64,592
+44,174
+216% +$434K 0.04% 513
2021
Q1 		$154K Sell
20,418
-36,732
-64% -$415K 0.01% 1442
2020
Q4 		$958K Buy
+57,150
New +$636K 0.05% 405

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cutler Group's CLOV Position: Q1 2024 in Review

Cutler Group reduced its Clover Health Investments (CLOV) stake by 1.6% in Q1 2024, selling an estimated $268 and leaving 18,000 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Cutler Group first reported a position in CLOV in Q4 2020 and has held it in 14 quarters since. The position peaked at $969K in Q3 2021. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2024.

  • Cutler Group held 18,000 shares of Clover Health Investments worth $14K as of Q1 2024.
  • Cutler Group sold 294 Clover Health Investments shares in Q1 2024, an estimated $268.
  • Clover Health Investments made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1139 holding.
  • Cutler Group first reported a position in Clover Health Investments in Q4 2020 and has held it in 14 quarters since.
  • Cutler Group's Clover Health Investments position peaked at $969K in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.